Browsing by Subject Cost-Benefit Analysis

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
2011Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trialAcera, A; Rodriguez, A; Trapero-Bertran, M; Soteras, P; Sanchez, N; Bonet, JM; Manresa, JM; Hidalgo, P; Toran, P; Prieto, G
2011A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.Dretzke, J; Edlin, R; Round, J; Connock, M; Hulme, C; Czeczot, J; Fry-Smith, A; McCabe, C; Meads, C